TP53 and neoplasm: ,6 Therapeutic strategies that have been developed to target mutp53, including small compounds, CRISPR/Cas9, small peptides, and immunotherapies, aim to eliminate mutp53 expression or restore the function of WT p53 in tumor cells.7, 8, 9 Although progress has been made, these therapeutic effects are unsatisfactory in the clinic.